What You Should Know:
– This company will used the seed funding to expand Ventricle Health’s heart failure management therapeutic model in collaboration with value-based care provider groups and payers, which can reduce the overall average annual cost of heart failure care by at least 30-50%.
Virtual Cardiology Clinical Reimagining Cardiac Care Delivery
1 in 4 admitted heart failure patients are readmitted to the hospital within 30 days of discharge. But, only 22% of eligible heart failure patients are on guideline-recommended drugs – stressing the importance of a reimagined care model for cardiology. In addition, Access challenges to get to a cardiologist in a timely manner after hospital discharges only exacerbates the problem of heart failure-related re-admissions. Today, the average wait time to secure a cardiology appointment in the U.S. is 26 days – time that can make all the difference in the outcomes and ultimate costs of caring for a heart failure patient.
Founded in 2021 by top heart failure cardiologist, Dr. Dan Bensimhon, Ventricle Health’s care model is anchored around well-established guideline-directed medical therapy (GDMT) pathways. They provide patients access to cardiology care appointments from their home in as little as three days. Ventricle Health’s home-based and virtually enabled care model can reduce the overall average annual cost of heart failure care by at least 30-50%.
The Company is operational and delivering high-impact virtual and home-based clinical services in support of Accountable Care Organizations (ACOs), primary care practices and their payer partners in the Mid-Atlantic, Texas, Ohio and Florida, with more markets to be announced in the near future.